Dance Biopharm's Unattributed VC - II Round

Dance Biopharm raised a round of funding on December 18, 2017. Investors include SternAegis Ventures.

Dance Biopharm is focused on the development of inhaled insulin products to treat diabetes patients worldwide. The Dance team consists of experts in all aspects of inhaled insulin development, and is …

Articles about Dance Biopharm's Unattributed VC - II Round: